DAX24.178 +0,6%ESt505.420 +0,8%Top 10 Crypto14,66 +1,1%Dow42.099 -0,6%Nas19.101 -0,5%Bitcoin96.235 +0,3%Euro1,1283 -0,1%Öl65,71 +1,1%Gold3.281 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 RENK RENK73 HENSOLDT HAG000 Tesla A1CX3T BYD A0M4W9 Lufthansa 823212 Siemens Energy ENER6Y D-Wave Quantum A3DSV9 Mercedes-Benz Group (ex Daimler) 710000 thyssenkrupp 750000 Deutsche Telekom 555750 Infineon 623100 Deutsche Bank 514000 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX positiv - Rekord im Blick -- Asiens Börsen letztlich freundlich -- NVIDIA übertrifft Erwartungen -- US-Gericht erklärt Trumps Zölle für rechtswidrig -- GSK, Bilfinger, Deutsche Telekom im Fokus
Top News
Deutsche Telekom-Aktie dennoch tiefer: S&P hebt Rating-Ausblick der Deutschen Telekom auf positiv an Deutsche Telekom-Aktie dennoch tiefer: S&P hebt Rating-Ausblick der Deutschen Telekom auf positiv an
AUTO1-Aktie fällt: UBS enttäuscht von Ausblick AUTO1-Aktie fällt: UBS enttäuscht von Ausblick
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Viatris Aktie

Handeln
Viatris Aktien-Sparplan
7,65 EUR +0,09 EUR +1,16 %
XETRA
8,59 USD -0,02 USD -0,23 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.8,94 Mrd. EUR

Div. Rendite3,86%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2QAME

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS92556V1061

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolVTRS

Viatris Aktien News

DatumMeistgelesen
PR NewswireViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireCLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025
PR NewswireViatris Announces Launch of First Clozapine Orally Disintegrating Tablet (ODT) in Canada
Wer­bungViatris-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireViatris to Participate in Upcoming Investor Conferences
PR NewswireViatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - VTRS
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
PR NewswireVIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS
PR NewswireShareholders that lost money on Viatris Inc.(VTRS) should contact Levi & Korsinsky about pending Class Action - VTRS
PR NewswireViatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
PR NewswireVIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains...
PR NewswireViatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
PR NewswireViatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential
PR NewswireViatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit - VTRS
PR NewswireViatris Announces Quarterly Dividend
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
PR NewswireViatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
PR NewswireJune 3, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against VTRS
PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireViatris to Present at the BofA Securities 2025 Healthcare Conference
PR NewswireSHAREHOLDER ALERT: Berger Montague Reminds Viatris (NASDAQ: VTRS) Investors of Class Action Lawsuit Deadline
PR NewswireNASDAQ: VTRS INVESTOR ALERT: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors of a June 3, 2025 Deadline
PR NewswireViatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder
PR NewswireVTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireVTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
PR NewswireViatris Appoints Hemanth J. Varghese as Chief Strategy Officer
PR NewswireVTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
PR NewswireContact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS)
PR NewswireInvestor Alert: Robbins LLP Informs Stockholders of the Viatris Inc. Class Action
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
PR NewswireViatris to Report First Quarter 2025 Financial Results on May 8, 2025
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
PR NewswireViatris to Present at the Barclays 27th Annual Global Healthcare Conference
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS
Wer­bung

Viatris News

Viatris News: auf dieser Seite finden Sie alle Viatris News und Nachrichten zur Viatris Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Viatris News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Viatris News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.